PTC Therapeutics NASDAQ: PTCT plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.
PTC Therapeutics Inc. (NASDAQ:PTCT) on Wednesday said it is expanding its rare disease portfolio through the planned acquisition of the ST-920 Fabry disease program from Sangamo Therapeutics in a competitive bankruptcy auction.
Enables engineers to create reusable custom CAD features using natural language and AI, no programming experience required Automates feature development through AI-assisted building, testing, debugging, and refinement Captures engineering knowledge as reusable CAD automation that can be shared across teams without ongoing AI interactions or recurring costs BOSTON, Aug. 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the availability of the new FeatureScript™ MCP Server capability in its Onshape® CAD and PDM platform. Available through its Onshape Labs™ initiative, the capability enables engineers to create custom CAD features using natural language and AI.
– Planned acquisition leverages existing regulatory and commercial infrastructure and leadership's experience in Fabry therapy commercialization – – ST-920 is a one-time administered AAV gene therapy for the enzyme deficient in Fabry disease with demonstrated long-term clinical benefits and safety profile – – BLA submission expected to be completed in Q4 2026 with potential for commercial launch in 2027 – – PTC will host a conference call today, Aug. 12, at 5 p.m. ET – WARREN, N.J.
Shares of PTC Inc. (NASDAQ: PTC - Get Free Report) have received a consensus rating of "Hold" from the fourteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company.
Bank of America Corp DE decreased its position in shares of PTC Inc. (NASDAQ: PTC) by 5.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 652,179 shares of the technology company's stock after selling 39,720 shares during the period. Bank of America Corp DE owned
On August 06, 2026, PTC Inc (PTC) shares rose 5.9% to a current price of $147.66, showing a notable improvement from a 52-week low of $108.50. Despite this posi
Launches Codebeamer 3.3, Codebeamer AI 1.2, and Pure Variants 7.3, strengthening traceability, change management, and AI governance Automates how engineering teams carry approved changes across product variants and controls who can approve them Introduces an AI Search Assistant powered by semantic search, helping teams quickly find more complete and accurate results BOSTON, Aug. 5, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the latest enhancements to its application lifecycle management (ALM) portfolio with the release of its Codebeamer® 3.3, Codebeamer AI 1.2, and Pure Variants™ 7.3 solutions. Together, the releases address two challenges engineering teams face regularly: keeping changes consistent across product variants and finding the right information within them.
BOSTON, Aug. 5, 2026 /PRNewswire/ -- PTC (Nasdaq: PTC) today announced that it will participate in the following conferences. What: Oppenheimer 29th Annual Technology, Internet & Communications Virtual Conference When: 1x1's on Wednesday, August 12, 2026 What: Citi's 2026 Global TMT Conference When: Wednesday, September 9, 2026 What: Berenberg European Conference When: 1x1's on Tuesday, December 1, 2026 What: Barclays 24th Annual Global Technology Conference When: Wednesday, December 9, 2026 View conference schedule HERE.
Simplifies how teams integrate systems, automate workflows, and manage information across the product ecosystem Helps accelerate workflow creation with pre-built templates, a library of low-code connectors, and an intuitive visual interface Introduces AI-powered product change summaries, automated BOM compliance checks, and enhanced Onshape-Arena connection features as part of the broader 2026.2 release BOSTON, Aug. 4, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of the Arena Connect™ capability within its Arena® product lifecycle management (PLM) and quality management system (QMS) 2026.2 release. Arena Connect helps manufacturers connect business applications, other Arena workspaces, and automated workflows across the product value chain, making it easier to move information between the systems teams rely on every day.
